Immunovant (IMVT)
(Delayed Data from NSDQ)
$27.87 USD
-1.00 (-3.46%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $27.88 +0.01 (0.04%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.52 |
EPS Last Quarter | -0.52 |
Last EPS Surprise | -20.93% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.11 |
Next Year | -2.31 |
EPS (TTM) | -1.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 65.29M |
# of Estimates | NA | NA | NA | 5 |
High Estimate | NA | NA | NA | 148.50M |
Low Estimate | NA | NA | NA | 6.77M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.52 | -0.54 | -2.11 | -2.31 |
# of Estimates | 7 | 7 | 10 | 6 |
Most Recent Consensus | -0.53 | -0.54 | -2.20 | -2.28 |
High Estimate | -0.39 | -0.40 | -1.67 | -1.67 |
Low Estimate | -0.58 | -0.68 | -2.61 | -2.70 |
Year ago EPS | -0.47 | -0.45 | -1.78 | -2.11 |
Year over Year Growth Est. | -10.64% | -20.00% | -18.54% | -9.23% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | -0.52 | -0.54 | -2.11 | -2.31 |
7 Days Ago | -0.52 | -0.54 | -2.11 | -2.31 |
30 Days Ago | -0.52 | -0.54 | -2.11 | -2.31 |
60 Days Ago | -0.52 | -0.53 | -2.10 | -2.25 |
90 Days Ago | -0.46 | -0.46 | -1.82 | -1.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.52 | -0.54 | -2.11 | -2.31 |
Zacks Consensus Estimate | -0.52 | -0.54 | -2.11 | -2.31 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.52 | -0.36 | -0.45 | -0.47 | NA |
Estimate | -0.43 | -0.44 | -0.46 | -0.44 | NA |
Difference | -0.09 | 0.08 | 0.01 | -0.03 | -0.01 |
Surprise | -20.93% | 18.18% | 2.17% | -6.82% | -1.85% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more